Literature DB >> 33761299

Attention to Immortal Time Bias in Critical Care Research.

Emily A Vail1,2, Hayley B Gershengorn3,4, Hannah Wunsch5,6,7, Allan J Walkey8.   

Abstract

Observational studies in critical care medicine offer a popular and practical approach to questions of treatment effectiveness. Although observational research is widely understood to be susceptible to design and interpretation challenges, one well-described source of bias-immortal time bias (ITB)-is frequently present yet often overlooked. ITB may be introduced by study design oversights or mishandled during data analysis. When present, ITB can create inappropriate estimates of the benefit or harm of an exposure or intervention. Studies examining treatments in critically ill patients may be particularly susceptible to ITB, with consequences for clinical adoption and design and initiation of randomized trials. In this Critical Care Perspective, we illustrate the persistent problem of ITB in observational research using recent studies of hydrocortisone, ascorbic acid, and thiamine therapy in patients with sepsis and septic shock. Of the eight studies examined, none contained enough design or reporting elements to rule out the presence of ITB. To mitigate the influence of ITB in future observational studies, we present a novel checklist to help readers assess the features of study design, analysis, and reporting that introduce ITB or obscure its presence. We recommend that commonly used tools designed to evaluate observational research studies should include an ITB assessment.

Entities:  

Keywords:  comparative effectiveness research; critical care medicine; statistical bias

Year:  2021        PMID: 33761299     DOI: 10.1164/rccm.202008-3238CP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Association of Early Steroid Administration With Outcomes of Children Hospitalized for COVID-19 Without Multisystem Inflammatory Syndrome in Children.

Authors:  Sandeep Tripathi; Meghana Nadiger; Jeremy S McGarvey; Aaron A Harthan; Monica Lombardo; Varsha P Gharpure; Nicholas Perkins; Kathleen Chiotos; Imran A Sayed; Erica C Bjornstad; Utpal S Bhalala; Umamaheswara Raju; Aaron S Miller; Heda Dapul; Vicki Montgomery; Karen Boman; Grace M Arteaga; Vikas Bansal; Neha Deo; Aysun Tekin; Ognjen Gajic; Vishakha K Kumar; Rahul Kashyap; Allan J Walkey
Journal:  JAMA Pediatr       Date:  2022-10-03       Impact factor: 26.796

2.  Beyond Confounding: Identifying Selection Bias in Observational Pulmonary and Critical Care Research.

Authors:  Andrew J Admon; Amy S B Bohnert; Colin R Cooke; Stephanie Parks Taylor
Journal:  Ann Am Thorac Soc       Date:  2022-07

3.  Outcomes and Predictors of Severe Hyperoxemia in Patients Receiving Mechanical Ventilation: A Single-Center Cohort Study.

Authors:  Sanjeev Tyagi; Christopher A Brown; Robert P Dickson; Michael W Sjoding
Journal:  Ann Am Thorac Soc       Date:  2022-08

4.  Vitamin C for ≥ 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study.

Authors:  Sun-Young Jung; Min-Taek Lee; Moon Seong Baek; Won-Young Kim
Journal:  Crit Care       Date:  2022-01-05       Impact factor: 9.097

5.  Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.

Authors:  Nicolas Massart; Virginie Maxime; Fabrice Bruneel; Charles-Edouard Luyt; Pierre Fillatre; Keyvan Razazi; Alexis Ferré; Pierre Moine; Francois Legay; Guillaume Voiriot; Marlene Amara; Francesca Santi; Saad Nseir; Stephanie Marque-Juillet; Rania Bounab; Nicolas Barbarot
Journal:  Ann Intensive Care       Date:  2021-12-24       Impact factor: 6.925

6.  Outcome after intubation for septic shock with respiratory distress and hemodynamic compromise: an observational study.

Authors:  Ting Yang; Yongchun Shen; John G Park; Phillip J Schulte; Andrew C Hanson; Vitaly Herasevich; Yue Dong; Philippe R Bauer
Journal:  BMC Anesthesiol       Date:  2021-10-25       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.